Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

By Staropoli I.   Frenkiel M.-P.   Megret F.   Deubel V.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1946-1954

Elsevier

Access to resources Recommend Favorite

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice

By Konishi E.   Yamaoka M.   Kurane I.   Mason P.W.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1133-1139

Elsevier

Access to resources Recommend Favorite

Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies

By Lu Y.   Raviprakash K.   Leao I.C.   Chikhlikar P.R.   Ewing D.   Anwar A.   Chougnet C.   Murphy G.   Hayes C.G.   August T.J.   Marques E.T.A.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2187-2198

Elsevier

Access to resources Recommend Favorite

Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice

By Kelly E.P.   Greene J.J.   King A.D.   Innis B.L.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2549-2559

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite